Baird Maintains Outperform on Merit Medical Systems, Raises Price Target to $109
Portfolio Pulse from Benzinga Newsdesk
Baird analyst David Rescott has maintained an 'Outperform' rating on Merit Medical Systems (NASDAQ:MMSI) and raised the price target from $107 to $109.
October 31, 2024 | 11:47 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Baird analyst David Rescott has maintained an 'Outperform' rating on Merit Medical Systems and increased the price target from $107 to $109, indicating positive expectations for the stock.
The increase in price target from $107 to $109 by Baird suggests a positive outlook for Merit Medical Systems. The 'Outperform' rating indicates that the analyst expects the stock to perform better than the market average, which could lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100